| Form type | Sec Links | Description | Filing date | Reporting date |
|---|---|---|---|---|
| SC 13G/A | Report | NONE | Jun 13, 2023 | |
| SC 13D/A | Report | SC 13D/A | Jun 12, 2023 | |
| SC 13D/A | Report | SC 13D/A | Jun 8, 2023 | |
| 8-K | Report | Data | 8-K | Jun 8, 2023 | Jun 6, 2023 |
| 8-K | Report | Data | 8-K | May 18, 2023 | May 18, 2023 |
| 10-Q | Report | Data | 10-Q | May 11, 2023 | Mar 31, 2023 |
| 8-K | Report | Data | 8-K | May 3, 2023 | May 1, 2023 |
| SC 13D/A | Report | GROWTH EQUITY OPPORTUNITIES 17, LLC / SATSUMA PHARMACEUTICALS -- 13D/A(#2E) | May 2, 2023 | |
| 10-K/A | Report | Data | 10-K/A | Apr 28, 2023 | Dec 31, 2022 |
| SC 13D/A | Report | SC 13D/A | Apr 18, 2023 | |
| SC 13D/A | Report | SC 13D/A | Apr 17, 2023 | |
| 8-K | Report | Data | 8-K | Apr 17, 2023 | Apr 11, 2023 |
| 10-K | Report | Data | 10-K | Mar 28, 2023 | Dec 31, 2022 |
| 8-K | Report | Data | 8-K | Mar 28, 2023 | Mar 28, 2023 |
| 8-K | Report | Data | 8-K | Feb 16, 2023 | Feb 16, 2023 |
| SC 13G/A | Report | Feb 14, 2023 | ||
| SC 13G/A | Report | AMENDMENT TO FORM SC 13G | Feb 10, 2023 | |
| SC 13G/A | Report | NONE | Feb 8, 2023 | |
| SC 13D/A | Report | GROWTH EQUITY OPPORTUNITIES 17, LLC / SATSUMA PHARMACEUTICALS -- 13D/A(#1) | Jan 27, 2023 | |
| 8-K | Report | Data | 8-K | Dec 20, 2022 | Dec 20, 2022 |
| 8-K | Report | Data | 8-K | Nov 30, 2022 | Nov 30, 2022 |
| SC 13G | Report | NONE | Nov 16, 2022 | |
| SC 13G/A | Report | Nov 16, 2022 | ||
| 8-K | Report | Data | 8-K | Nov 14, 2022 | Nov 14, 2022 |
| 8-K | Report | Data | 8-K | Nov 3, 2022 | Nov 3, 2022 |
| 10-Q | Report | Data | 10-Q | Nov 3, 2022 | Sep 30, 2022 |
| 8-K | Report | Data | 8-K | Nov 3, 2022 | Nov 3, 2022 |
| 8-K | Report | Data | 8-K | Oct 28, 2022 | Oct 26, 2022 |
| 8-K | Report | Data | 8-K | Sep 20, 2022 | Sep 20, 2022 |
| 10-Q | Report | Data | 10-Q | Aug 9, 2022 | Jun 30, 2022 |
| 8-K | Report | Data | 8-K | Aug 9, 2022 | Aug 9, 2022 |
| 8-K | Report | Data | 8-K | Jun 7, 2022 | Jun 3, 2022 |
| 10-Q | Report | Data | STSA-Q1-2022 | May 10, 2022 | Mar 31, 2022 |
| 8-K | Report | Data | 8-K | May 10, 2022 | May 10, 2022 |
| 10-K | Report | Data | 10-K | Mar 15, 2022 | Dec 31, 2021 |
| 8-K | Report | Data | 8-K | Mar 15, 2022 | Mar 15, 2022 |
| SC 13G/A | Report | Feb 25, 2022 | ||
| SC 13G/A | Report | SC 13G/A | Feb 14, 2022 | |
| SC 13G | Report | Feb 14, 2022 | ||
| SC 13G/A | Report | AMENDMENT TO FORM SC 13G | Feb 11, 2022 | |
| 10-Q | Report | Data | 10-Q | Nov 9, 2021 | Sep 30, 2021 |
| 8-K | Report | Data | 8-K | Nov 9, 2021 | Nov 9, 2021 |
| SC 13G/A | Report | SC 13G/A | Oct 19, 2021 | |
| 8-K | Report | Data | FORM 8-K | Oct 12, 2021 | Oct 11, 2021 |
| 10-Q | Report | Data | 10-Q | Aug 10, 2021 | Jun 30, 2021 |
| 8-K | Report | 8-K | Aug 10, 2021 | Aug 10, 2021 |
| 8-K | Report | 8-K | Jun 16, 2021 | Jun 16, 2021 |
| 8-K | Report | FORM 8-K | Jun 2, 2021 | Jun 1, 2021 |
| 10-Q | Report | Data | 10-Q | May 11, 2021 | Mar 31, 2021 |
| 8-K | Report | 8-K | May 11, 2021 | May 11, 2021 |
| SC 13G/A | Report | MS AMENDMENT | Apr 9, 2021 | |
| SC 13D | Report | SCHEDULE 13D | Mar 31, 2021 | |
| 10-K | Report | Data | 10-K - 2020 | Mar 25, 2021 | Dec 31, 2020 |
| 8-K | Report | FORM 8-K | Mar 25, 2021 | Mar 25, 2021 |
| SC 13D | Report | GROWTH EQUITY OPPORTUNITIES 17, LLC / SATSUMA PHARMACEUTICALS -- 13D | Mar 15, 2021 | |
| SC 13G | Report | INITIAL FILING | Mar 15, 2021 | |
| SC 13D/A | Report | SC 13D/A | Mar 2, 2021 | |
| 8-K | Report | FORM 8-K | Mar 1, 2021 | Feb 26, 2021 |
| SC 13G/A | Report | SC 13G/A | Feb 16, 2021 | |
| SC 13G/A | Report | MS AMENDMENT | Feb 12, 2021 | |
| SC 13G | Report | MS INITIAL | Dec 18, 2020 | |
| SC 13G/A | Report | SC 13G/A | Dec 4, 2020 | |
| 10-Q | Report | Data | 10-Q | Nov 10, 2020 | Sep 30, 2020 |
| 8-K | Report | FORM 8-K | Nov 10, 2020 | Nov 10, 2020 |
| SC 13G/A | Report | SEC SCHEDULE 13G | Oct 9, 2020 | |
| 8-K | Report | 8-K | Sep 10, 2020 | Sep 10, 2020 |
| 10-Q | Report | Data | 10-Q | Aug 11, 2020 | Jun 30, 2020 |
| 8-K | Report | FORM 8-K | Aug 11, 2020 | Aug 11, 2020 |
| SC 13G/A | Report | SEC SCHEDULE 13G | Aug 10, 2020 | |
| 8-K | Report | FORM 8-K | Jul 7, 2020 | Jul 2, 2020 |
| 8-K | Report | FORM 8-K | Jun 15, 2020 | Jun 12, 2020 |
| 10-Q | Report | Data | 10-Q | May 12, 2020 | Mar 31, 2020 |
| 8-K | Report | FORM 8-K | May 12, 2020 | May 12, 2020 |
| 10-K | Report | Data | 10-K | Mar 10, 2020 | Dec 31, 2019 |
| 8-K | Report | FORM 8-K | Mar 10, 2020 | Mar 10, 2020 |
| SC 13G/A | Report | SC 13G/A | Feb 14, 2020 | |
| SC 13G/A | Report | Feb 14, 2020 | ||
| SC 13G | Report | ACQUISITION OF BENEFICIAL OWNERSHIP | Feb 13, 2020 | |
| SC 13G/A | Report | SEC SCHEDULE 13G | Jan 27, 2020 | |
| SC 13G | Report | SC 13G | Nov 27, 2019 | |
| 10-Q | Report | Data | 10-Q | Nov 12, 2019 | Sep 30, 2019 |
| 8-K | Report | 8-K | Nov 12, 2019 | Nov 12, 2019 |
| SC 13G | Report | Oct 21, 2019 | ||
| SC 13G | Report | SEC SCHEDULE 13G | Oct 10, 2019 | |
| SC 13G | Report | SCHEDULE 13G | Sep 23, 2019 | |
| SC 13D | Report | SCHEDULE 13D | Sep 17, 2019 | |
| 8-K | Report | FORM 8-K | Sep 17, 2019 | Sep 17, 2019 |